1-(5-O-BENZYL-2,3-DIDEOXY-3-FLUORO-BETA-D-RIBOFURANOSYL)-THYMINE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 5vPPlLRByU8 |
|---|---|
| InChI | InChI=1S/C17H19FN2O4/c1-11-8-19-17(22)20(16(11)21)15-7-13(18)14(24-15)10-23-9-12-5-3-2-4-6-12/h2-6,8,13-15H,7,9-10H2,1H3,(H,19,22)/t13-,14+,15+/m0/s1 |
| InChIKey | RPBFLWKEUVVXBF-RRFJBIMHSA-N |
| Mol Weight | 334.35 g/mol |
| Molecular Formula | C17H19FN2O4 |
| Exact Mass | 334.132885 g/mol |
| Enantiomer InChIKey | RPBFLWKEUVVXBF-ILXRZTDVSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
N-(2-hydroxy-3-fluoro-4-hydroxymethyl-5-oxacyclopentanyl)-1,3-diaza-2,4-dioxo-5-cyclohexene
3-TETRAHYDROPYRANYL-5-ETHOXYCARBONYL-URACIL
N-(2,3-dihydroxy-4-fluoromethyl-5-oxacyclopentanyl)-1,3-diaza-2,4-dioxo-5-cyclohexene
N-(2-fluoro-3-hydroxy-4-hydroxymethyl-5-oxacyclopentanyl)-1,3-diaza-2,4-dioxo-5-cyclohexene
5'-O-BENZOYL-3'-DEOXY-3'-MERCAPTOTHYMIDINE
N-(2,3-dihydroxy-4-bromomethyl-5-oxacyclopentanyl)-1,3-diaza-2,4-dioxo-5-cyclohexene
N-(2-hydroxy-3-bromo-4-hydroxymethyl-5-oxacyclopentanyl)-1,3-diaza-2,4-dioxo-5-cyclohexene
1-(2,3-Dideoxy-3-fluoro-.beta.,D-erythro-pentofuranosyl]-5-fnitro-2,4(1H,3H)-pyrimidinedione
benzoic acid [(2R,3S,5R)-5-(2,4-diketo-5-methyl-pyrimidin-1-yl)-3-hydroxy-tetrahydrofuran-2-yl]methyl ester
3'-O-[2-(N-METHYLPIPERIDINIUM)-ETHYL]-THYMIDINE-IODIDE
| Title | Journal or Book | Year |
|---|---|---|
| Stereoselective Synthesis of 2‘,3‘-Dideoxy-3‘-fluoro-2‘-phenylselenenyl- β-nucleosides from Phenyl 1-Seleno-α-arabino-furanosides through Consecutive 1,2-Migration and Glycosylation under Mitsunobu Conditions. A New Entry to 2‘,3‘-Dideoxy-3‘-fluoronucleosides | The Journal of Organic Chemistry | 1999 |
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.